These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Utilization, patency, and complications associated with vascular access for hemodialysis in the United States. Arhuidese IJ, Orandi BJ, Nejim B, Malas M. J Vasc Surg; 2018 Oct; 68(4):1166-1174. PubMed ID: 30244924 [Abstract] [Full Text] [Related]
3. Outcomes of autogenous fistulas and prosthetic grafts for hemodialysis access in diabetic and nondiabetic patients. Arhuidese IJ, Purohit A, Elemuo C, Parkerson GR, Shames ML, Malas MB. J Vasc Surg; 2020 Dec; 72(6):2088-2096. PubMed ID: 32276026 [Abstract] [Full Text] [Related]
4. Gender-Based Utilization and Outcomes of Autogenous Fistulas and Prosthetic Grafts for Hemodialysis Access. Arhuidese IJ, Faateh M, Meshkin RS, Calero A, Shames M, Malas MB. Ann Vasc Surg; 2020 May; 65():196-205. PubMed ID: 31626935 [Abstract] [Full Text] [Related]
5. A comparison of patency and interventions in thigh versus Hemodialysis Reliable Outflow grafts for chronic hemodialysis vascular access. Brownie ER, Kensinger CD, Feurer ID, Moore DE, Shaffer D. J Vasc Surg; 2016 Nov; 64(5):1392-1399. PubMed ID: 27444362 [Abstract] [Full Text] [Related]
6. Vascular access for hemodialysis in the elderly. Arhuidese IJ, Cooper MA, Rizwan M, Nejim B, Malas MB. J Vasc Surg; 2019 Feb; 69(2):517-525.e1. PubMed ID: 30683199 [Abstract] [Full Text] [Related]
7. The forearm arteriovenous graft between the brachial artery and the brachial vein as a reliable dialysis vascular access for patients with inadequate superficial veins. Fumagalli G, Trovato F, Migliori M, Panichi V, De Pietro S. J Vasc Surg; 2019 Jul; 70(1):199-207.e4. PubMed ID: 30894304 [Abstract] [Full Text] [Related]
8. Bovine carotid artery biologic graft outperforms expanded polytetrafluoroethylene for hemodialysis access. Arhuidese I, Reifsnyder T, Islam T, Karim O, Nejim B, Obeid T, Qazi U, Malas M. J Vasc Surg; 2017 Mar; 65(3):775-782. PubMed ID: 28236920 [Abstract] [Full Text] [Related]
9. Outcomes of prosthetic upper arm arteriovenous graft vs brachiobasilic fistula for hemodialysis access. Lu E, Baril DT, Arbabi CN, Chou EL, Azizzadeh A, Gupta N. J Vasc Surg; 2024 Oct; 80(4):1083-1089.e2. PubMed ID: 38909916 [Abstract] [Full Text] [Related]
10. Single Asian Center Experience Using the Flixene™ Early Cannulation Graft for Hemodialysis Access Creation. Chang J, Yap HY, Chan SL, Lee QWS, Tan RY, Pang SC, Tan CS, Chong TT, Tang TY. Ann Vasc Surg; 2021 May; 73():171-177. PubMed ID: 33373770 [Abstract] [Full Text] [Related]
11. Cryopreserved venous allograft is an acceptable conduit in patients with current or prior angioaccess graft infection. Harlander-Locke MP, Lawrence PF, Ali A, Bae E, Kohn J, Abularrage C, Ricci M, Lemmon GW, Peralta S, Hsu J, Vascular Low-Frequency Disease Consortium. J Vasc Surg; 2017 Oct; 66(4):1157-1162. PubMed ID: 28647193 [Abstract] [Full Text] [Related]
12. Arteriovenous fistulae vs. arteriovenous grafts: a retrospective review of 1,700 consecutive vascular access cases. Schild AF, Perez E, Gillaspie E, Seaver C, Livingstone J, Thibonnier A. J Vasc Access; 2008 Oct; 9(4):231-5. PubMed ID: 19085891 [Abstract] [Full Text] [Related]
13. Immediate-access grafts provide comparable patency to standard grafts, with fewer reinterventions and catheter-related complications. Wagner JK, Dillavou E, Nag U, Ali AA, Truong S, Chaer R, Hager E, Yuo T, Makaroun M, Avgerinos ED. J Vasc Surg; 2019 Mar; 69(3):883-889. PubMed ID: 30528400 [Abstract] [Full Text] [Related]
14. Complete versus partial excision of infected arteriovenous grafts: Does remnant graft material impact outcomes? Liu RH, Fraser CD, Zhou X, Beaulieu RJ, Reifsnyder T. J Vasc Surg; 2020 Jan; 71(1):174-179. PubMed ID: 31248761 [Abstract] [Full Text] [Related]
15. Age-based outcomes of autogenous fistulas for hemodialysis access. Arhuidese IJ, King RW, Elemuo C, Agbonkhese G, Calero A, Malas MB. J Vasc Surg; 2021 Nov; 74(5):1636-1642. PubMed ID: 34298119 [Abstract] [Full Text] [Related]
16. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access. Shemesh D, Goldin I, Hijazi J, Zaghal I, Berelowitz D, Verstandig A, Olsha O. J Vasc Surg; 2015 Jul; 62(1):115-22. PubMed ID: 25770987 [Abstract] [Full Text] [Related]
17. Impact of Body Mass Index on Outcomes of Autogenous Fistulas for Hemodialysis Access. Arhuidese IJ, Holscher CM, Elemuo C, Parkerson GR, Johnson BL, Malas MB. Ann Vasc Surg; 2020 Oct; 68():192-200. PubMed ID: 32339695 [Abstract] [Full Text] [Related]
18. The end stage of dialysis access: femoral graft or HeRO vascular access device. Kudlaty EA, Pan J, Allemang MT, Kendrick DE, Kashyap VS, Wong VL. Ann Vasc Surg; 2015 Jan; 29(1):90-7. PubMed ID: 24952298 [Abstract] [Full Text] [Related]
19. Comparison of FLIXENE™ and standard PTFE arteriovenous graft for early haemodialysis. Chiang N, Hulme KR, Haggart PC, Vasudevan T. J Vasc Access; 2014 Jan; 15(2):116-22. PubMed ID: 24531998 [Abstract] [Full Text] [Related]
20. Clinical effectiveness of open thrombectomy for thrombosed autogenous arteriovenous fistulas and grafts. Ghaffarian AA, Al-Dulaimi R, Kraiss LW, Sarfati M, Griffin CL, Smith BK, Donald G, Brooke BS. J Vasc Surg; 2018 Jul; 68(1):189-196. PubMed ID: 29526376 [Abstract] [Full Text] [Related] Page: [Next] [New Search]